Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and analgesic efficacy of loxapine in refractory chemotherapy-induced neuropathic pain
2014-005440-17Phase 2Terminated
- Sponsor
- University of Witten/Herdecke
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of loxapine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by University of Witten/Herdecke. Primary endpoint: Primary tolerability endpoint. Started Mar 2015; status: terminated.
02
Drugs
loxapine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on 2014-005440-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005440-17.